413 related articles for article (PubMed ID: 26217958)
1. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
2. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
3. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
4. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
Tong L; Wu H; Wang MD
Methods; 2021 May; 189():74-85. PubMed ID: 32763377
[TBL] [Abstract][Full Text] [Related]
5. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
6. Robust pathway-based multi-omics data integration using directed random walks for survival prediction in multiple cancer studies.
Kim SY; Jeong HH; Kim J; Moon JH; Sohn KA
Biol Direct; 2019 Apr; 14(1):8. PubMed ID: 31036036
[TBL] [Abstract][Full Text] [Related]
7. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
8. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract][Full Text] [Related]
9. Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancers.
Hsiao TH; Chiu YC; Hsu PY; Lu TP; Lai LC; Tsai MH; Huang TH; Chuang EY; Chen Y
Sci Rep; 2016 Mar; 6():23035. PubMed ID: 26972162
[TBL] [Abstract][Full Text] [Related]
10. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
[TBL] [Abstract][Full Text] [Related]
11. Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer.
Wang L; Xiao Y; Ping Y; Li J; Zhao H; Li F; Hu J; Zhang H; Deng Y; Tian J; Li X
PLoS One; 2014; 9(8):e104282. PubMed ID: 25137136
[TBL] [Abstract][Full Text] [Related]
12. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
13. Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Fleck JL; Pavel AB; Cassandras CG
BMC Syst Biol; 2016 Jan; 10():12. PubMed ID: 26810975
[TBL] [Abstract][Full Text] [Related]
14. Integrative network analysis of TCGA data for ovarian cancer.
Zhang Q; Burdette JE; Wang JP
BMC Syst Biol; 2014 Dec; 8():1338. PubMed ID: 25551281
[TBL] [Abstract][Full Text] [Related]
15. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
[TBL] [Abstract][Full Text] [Related]
16. Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies.
Ben-Hamo R; Efroni S
BMC Syst Biol; 2012 Jan; 6():3. PubMed ID: 22236809
[TBL] [Abstract][Full Text] [Related]
17. A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
Dutta B; Pusztai L; Qi Y; André F; Lazar V; Bianchini G; Ueno N; Agarwal R; Wang B; Shiang CY; Hortobagyi GN; Mills GB; Symmans WF; Balázsi G
Br J Cancer; 2012 Mar; 106(6):1107-16. PubMed ID: 22343619
[TBL] [Abstract][Full Text] [Related]
18. Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway.
Wang YQ; Zhang JR; Li SD; He YY; Yang YX; Liu XL; Wan XP
Cancer Sci; 2010 Jul; 101(7):1618-23. PubMed ID: 20487263
[TBL] [Abstract][Full Text] [Related]
20. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
